Novo Nordisk says Health Canada has approved its weight loss drug Wegovy to reduce the risk of heart attacks in some adults. Kyle Benning has the details and more in Health Matters for Nov. 27, 2024.
Health Matters
Health Matters: Wegovy approved to reduce heart attack risk
More Videos
-
Health Matters: Dozens sickened after eating BC oysters
-
Health Matters: Nestle launches protein shots in U.S.
-
Health Matters: Canada Post workers seek improved health and safety measures on the job
-
Health Matters: LGBTQ2 advocates try to halt Alberta’s transgender bill
-
Cancer costs a patient $33K, Canadian Cancer Society report says
-
Health Matters: Alberta signs onto federal deal for rare disease drugs
You are viewing an Accelerated Mobile Webpage.
View Original Article